{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:35:20Z","timestamp":1789504520878,"version":"build-2803163510"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Health Office Baglung","award":["01"],"award-info":[{"award-number":["01"]}]}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:sec id=\"sec028\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>Lymphatic filariasis (LF), a neglected tropical disease, remains a significant public health challenge in endemic regions including Baglung Municipality of Nepal. This study investigates the acceptability of mass drug administration (MDA) for LF in Baglung Municipality of Nepal.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec029\">\n<jats:title>Methodology<\/jats:title>\n<jats:p>A cross-sectional, mixed-method study was conducted in Baglung Municipality among 272 community people. Three Focus Group Discussions (FGD) were conducted among 25 commmunity members. Quantitative data were collected using pretested structured questionnaires and FGDs were conducted using structured guideline. Probability proportional to size sampling was done to select desired number of participants. EpiData 3.1 was used for data entry and IBM SPSS 22 was employed for quantitative data analysis. Descriptive statistics and logistic regression was applied. Similarly, thematic analysis was done for qualitative data analysis.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec030\">\n<jats:title>Results<\/jats:title>\n<jats:p>The study revealed that 84.2% were aware of MDA with 48.5% of participants having good knowledge about LF. About 59.3% and 45.2% had a positive attitude towards MDA and LF respectively. More than four fifth (80.5%) of the participants had accepted the MDA campaign with 91.5% having received MDA medication. Significant factors for MDA acceptability included educational status, attitude towards MDA, fear of side effects, and medication received. Qualitative data highlighted the strong influence of effective communication by health workers on MDA acceptance.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec031\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Knowledge on LF was found low among the participants with lesser proportion having positive attitude towards LF; highlighting the need for an increase in knowledge and attitude towards LF. The study shows the high level of acceptability of MDA; primarily influenced by the effective communication by health workers and the public trust in health services. Health workers led community-based strategies and programs are recommended for the high acceptance of MDA and the development of a positive attitude for better compliance.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pgph.0004910","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T17:27:22Z","timestamp":1753118842000},"page":"e0004910","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Acceptability of mass drug administration for lymphatic filariasis in Baglung Municipality of Nepal: A mixed-method study"],"prefix":"10.1371","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5714-3905","authenticated-orcid":true,"given":"Muskan","family":"Pudasainee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4108-4514","authenticated-orcid":true,"given":"Damaru Prasad","family":"Paneru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baburam","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0963-132X","authenticated-orcid":true,"given":"Prabin","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0926-0450","authenticated-orcid":true,"given":"Anil","family":"Khanal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2789-9561","authenticated-orcid":true,"given":"Bibash","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4675-0390","authenticated-orcid":true,"given":"Shiksha","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4706-2183","authenticated-orcid":true,"given":"Chiranjivi","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"issue":"9","key":"pgph.0004910.ref001","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(20)30286-2","article-title":"The global distribution of lymphatic filariasis, 2000\u201318: a geospatial analysis","volume":"8","author":"EA Cromwell","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"9","key":"pgph.0004910.ref002","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(20)30323-5","article-title":"Progress towards global elimination of lymphatic filariasis","volume":"8","author":"J Kamgno","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"2","key":"pgph.0004910.ref003","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00436-020-06991-y","article-title":"Lymphatic filariasis in Asia: a systematic review and meta-analysis","volume":"120","author":"N Bizhani","year":"2021","journal-title":"Parasitol Res"},{"key":"pgph.0004910.ref004","author":"WHO","year":"2023"},{"issue":"12","key":"pgph.0004910.ref005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001366","article-title":"The emerging story of disability associated with lymphatic filariasis: a critical review","volume":"5","author":"LM Zeldenryk","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"pgph.0004910.ref006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010215","article-title":"Community perceptions and acceptability of mass drug administration for the control of neglected tropical diseases in Asia-Pacific countries: A systematic scoping review of qualitative research","volume":"16","author":"E Mitchell","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pgph.0004910.ref007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011882","article-title":"The lymphatic filariasis treatment study landscape: A systematic review of study characteristics and the case for an individual participant data platform","volume":"18","author":"LT Freitas","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pgph.0004910.ref008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011932","article-title":"Assessment of microfilaremia in \u201chotspots\u201d of four lymphatic filariasis endemic districts of Nepal during post-MDA surveillance","volume":"18","author":"PK Mehta","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"key":"pgph.0004910.ref009","year":"2023"},{"issue":"1","key":"pgph.0004910.ref010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-2883-2-7","article-title":"Mapping of lymphatic filariasis in Nepal","volume":"2","author":"JB Sherchand","year":"2003","journal-title":"Filaria J"},{"key":"pgph.0004910.ref011","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3126\/eco.v13i0.1626","article-title":"A Prospective Study of Lymphatic Filariasis in an Endemic Village of Kapilbastu District, Nepal","volume":"13","author":"R Gupta","year":"2009","journal-title":"Ecoprint"},{"issue":"8","key":"pgph.0004910.ref012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007009","article-title":"Exploring factors affecting quality implementation of lymphatic filariasis mass drug administration in Bole and Central Gonja Districts in Northern Ghana","volume":"14","author":"AK Manyeh","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pgph.0004910.ref013","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s41182-021-00305-3","article-title":"Evaluating context-specific evidence-based quality improvement intervention on lymphatic filariasis mass drug administration in Northern Ghana using the RE-AIM framework","volume":"49","author":"AK Manyeh","year":"2021","journal-title":"Trop Med Health"},{"issue":"9","key":"pgph.0004910.ref014","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4103\/1995-7645.380729","article-title":"Elimination of lymphatic filariasis: Where do we stand so far?","volume":"16","author":"A Sinha","year":"2023","journal-title":"Asian Pacific Journal of Tropical Medicine"},{"key":"pgph.0004910.ref015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2049-9957-3-31","article-title":"Mass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance","volume":"3","author":"MA Hussain","year":"2014","journal-title":"Infect Dis Poverty"},{"issue":"6","key":"pgph.0004910.ref016","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-3156.2004.01247.x","article-title":"Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India","volume":"9","author":"BV Babu","year":"2004","journal-title":"Trop Med Int HealthTM IH"},{"issue":"19","key":"pgph.0004910.ref017","doi-asserted-by":"crossref","first-page":"12971","DOI":"10.3390\/ijerph191912971","article-title":"Factors Associated with the Acceptability of Mass Drug Administration for Filariasis: A Systematic Review","volume":"19","author":"AFN Abdul Halim","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"pgph.0004910.ref018","doi-asserted-by":"crossref","DOI":"10.1136\/bmjph-2023-000546","article-title":"Responsiveness of services rendered at primary healthcare facilities of Bharatpur, Nepal: a cross-sectional study","volume":"2","author":"A Adhikari","year":"2024","journal-title":"BMJ Public Health"},{"issue":"11","key":"pgph.0004910.ref019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002447","article-title":"A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis","volume":"7","author":"A Krentel","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"pgph.0004910.ref020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009596","article-title":"Assessing factors influencing communities\u2019 acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana","volume":"15","author":"RA Niles","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"pgph.0004910.ref021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009002","article-title":"A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis","volume":"15","author":"A Krentel","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"pgph.0004910.ref022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0002476","article-title":"Knowledge and perceptions of lymphatic filariasis patients in selected hotspot endemic communities in southern Ghana","volume":"3","author":"A Kwarteng","year":"2023","journal-title":"PLOS Glob Public Health"},{"issue":"10","key":"pgph.0004910.ref023","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/tropicalmed7100273","article-title":"A Comparative Study of Lymphatic Filariasis-Related Perceptions among Treated and Non-Treated Individuals in the Ahanta West Municipality of Ghana","volume":"7","author":"CS Ahorlu","year":"2022","journal-title":"Trop Med Infect Dis"},{"issue":"1","key":"pgph.0004910.ref024","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1756-3305-1-14","article-title":"Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines","volume":"1","author":"MLE Amarillo","year":"2008","journal-title":"Parasit Vectors"},{"issue":"7","key":"pgph.0004910.ref025","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1179\/000349809X12459740922255","article-title":"Mass drug administration against filariasis in India: perceptions and practices in a rural community in Kerala","volume":"103","author":"S Aswathy","year":"2009","journal-title":"Ann Trop Med Parasitol"},{"key":"pgph.0004910.ref026","article-title":"Awareness, acceptance and attitude of public towards mass drug administration programme for the elimination of lymphatic filariasis- a descriptive study","author":"J Chacko Ann","year":"2016","journal-title":"GJRA"},{"issue":"27","key":"pgph.0004910.ref027","first-page":"124","article-title":"Factors determining non-compliance to mass drug administration for lymphatic filariasis elimination in endemic districts of Nepal","volume":"12","author":"RK Adhikari","year":"2014","journal-title":"J Nepal Health Res Counc"},{"issue":"1","key":"pgph.0004910.ref028","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s10900-014-9891-1","article-title":"Awareness and coverage of mass drug administration for elimination of lymphatic filariasis: a community based cross sectional study in Nepal","volume":"40","author":"RK Adhikari","year":"2015","journal-title":"J Community Health"},{"issue":"5","key":"pgph.0004910.ref029","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.trstmh.2006.09.002","article-title":"Factors influencing drug compliance in the mass drug administration programme against filariasis in the Western province of Sri Lanka","volume":"101","author":"S Gunawardena","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"pgph.0004910.ref030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000728","article-title":"Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs","volume":"4","author":"PT Cantey","year":"2010","journal-title":"PLoS Negl Trop Dis"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0004910","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T17:27:28Z","timestamp":1753118848000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0004910"}},"subtitle":[],"editor":[{"given":"Julia","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0004910","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]}}}